Osteoporosis
📧 Sign up to get email alerts when something new happens for Osteoporosis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2015-11-30FDA Approved: FOSAMAX PLUS D — Supplemental Application (Organon LLC)
FDA approved a supplemental application for FOSAMAX PLUS D (alendronate with cholecalciferol) submitted by Organon LLC.
-
FDA approval · 2015-11-30FDA Approved: FOSAMAX — Supplemental Application (Organon LLC)
FDA approved a supplemental application for FOSAMAX (alendronate sodium) from Organon LLC.
-
FDA approval · 2015-11-30FDA Approved: RISEDRONATE SODIUM — Original Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved Sun Pharmaceutical Industries' risendronate sodium generic product under an Original Application (ANDA). Risendronate sodiu…
-
CLINICAL_TRIALS trial_result · 2015-11-26Clinical Trial Update: Dietary Intake of Salmon and Bone Health [NA]
This completed clinical trial investigated whether higher salmon dietary intake influences bone health in individuals with osteoporosis.
-
FDA approval · 2015-11-23FDA Approved: TERIPARATIDE — Supplemental Application (Prasco Laboratories)
The FDA approved a supplemental application for teriparatide submitted by Prasco Laboratories.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-11-23Clinical Trial Update: Osteoporosis and Fall Prevention High Risk Population Intervention and Follow up in the Metropolitan Area [NA]
This completed clinical trial evaluated osteoporosis and fall-prevention interventions in a high-risk population in the metropolitan area. T…
-
CLINICAL_TRIALS trial_result · 2015-11-20Clinical Trial Update: Hypovitaminosis D : A Link Between Bone/Mineral and Fat/Fuel Metabolism [Phase 3]
A Phase 3 clinical trial assessing the relationship between vitamin D deficiency and bone, mineral, and metabolic (fat/fuel) processes, with…
-
FDA approval · 2015-11-19FDA Approved: ZOLEDRONIC ACID — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for Zoledronic Acid from Hikma Pharmaceuticals USA Inc., resulting in a supplemental approval fo…
-
CLINICAL_TRIALS trial_result · 2015-11-03Clinical Trial Update: Osteoporosis Disease Management Demonstration Project (0000-040) [NA]
This update notes the completion of a clinical trial on osteoporosis disease management sponsored by Merck Sharp & Dohme LLC.
-
CLINICAL_TRIALS trial_result · 2015-11-03Clinical Trial Update: Clinical Value of Self-assessment Risk of Osteoporosis in Chinese
A completed clinical trial evaluating the clinical value of self-assessment risk for osteoporosis in Chinese individuals.
-
CLINICAL_TRIALS trial_result · 2015-11-02Clinical Trial Update: Comparison of Osteoporosis Disease Management Strategies (0000-039) [NA]
This clinical trial update notes completion of a study comparing osteoporosis disease management strategies (NCT00145080) sponsored by Merck…
-
FDA approval · 2015-10-31FDA Approved: CALCITONIN SALMON — Supplemental Application (Apotex Corp.)
FDA approved a supplemental application from Apotex Corp. for calcitonin salmon (generic), resulting in an updated approval under the ANDA p…
-
CLINICAL_TRIALS trial_result · 2015-10-30Clinical Trial Update: Clinical Study of Efficacy and Safety of Chung A Won in Women's Patients With Osteoporosis [Phase 2]
A Phase 2 trial evaluating the efficacy and safety of Chung A Won in women with osteoporosis has completed.
-
CLINICAL_TRIALS trial_result · 2015-10-29Clinical Trial Update: Effects of Hesperidin on Bone Mineral Density and Bone Metabolism of Postmenopausal Women [Phase 3]
Phase 3 trial evaluating the effects of hesperidin on bone mineral density and bone metabolism in postmenopausal women with osteoporosis or …
-
CLINICAL_TRIALS research · 2015-10-27Clinical Trial Update: A One-year Randomized Controlled Trial Evaluating the Impact of Pioglitazone Versus Linagliptin on Bone Turnover Markers [Phase 4]
A one-year, randomized trial compares pioglitazone versus linagliptin to assess their impact on bone turnover markers in individuals with os…
-
FDA label_change · 2015-10-23FDA Approved: RISEDRONATE SODIUM — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for Risendronate Sodium from Sun Pharmaceutical Industries to update labeling for the generic os…
-
FDA label_change · 2015-10-22FDA Approved: ACTONEL — Supplemental Application (Allergan, Inc.)
FDA overview documenting Allergan's supplemental application for Actonel (risendronate sodium) to update labeling.
-
CLINICAL_TRIALS trial_result · 2015-10-22Clinical Trial Update: Systemic Vitamin D Supplementation in Dental Implants Patients [Phase 4]
A Phase 4 trial investigating systemic vitamin D supplementation in osteoporosis patients receiving dental implants has completed.
-
CLINICAL_TRIALS trial_result · 2015-10-21Clinical Trial Update: Exercise for Physical Health in Men With Prostate Cancer [NA]
This entry provides an update on a clinical trial evaluating an exercise program to improve physical health in men with prostate cancer.
-
CLINICAL_TRIALS trial_result · 2015-10-19Clinical Trial Update: Musculoskeletal Effects of Bicarbonate [Phase 2]
Phase 2 trial evaluating the musculoskeletal effects of sodium bicarbonate, with results posted after completion, focusing on muscle loss, f…
-
FDA approval · 2015-10-19FDA Approved: ZOLEDRONIC ACID — Supplemental Application (BPI Labs LLC)
FDA approves a supplemental application for zoledronic acid from BPI Labs LLC under ANDA 202930. This action supports continued availability…
-
CLINICAL_TRIALS trial_result · 2015-10-19Clinical Trial Update: Effect of HIV Infection and Highly Active Antiretroviral Treatment (HAART) on Bone Homeostasis
This completed clinical trial evaluated how HIV infection and highly active antiretroviral therapy (HAART) influence bone homeostasis. It fo…
-
FDA approval · 2015-10-16FDA Approved: IBANDRONATE SODIUM — Original Application (Apotex Corp.)
FDA approved the original application for ibandronate sodium (generic) by Apotex Corp., enabling generic access to the osteoporosis treatmen…
-
CLINICAL_TRIALS research · 2015-10-16Clinical Trial Update: Active Rehabilitation in Osteoporotic Patients [NA]
Clinical trial update indicates the completion of a study on active rehabilitation for patients with osteoporosis. The update does not inclu…
-
CLINICAL_TRIALS trial_result · 2015-10-14Clinical Trial Update: The Relationship Between Osteoporosis and Chronic Oral Anticoagulation Therapy With Warfarin
The study examined the relationship between osteoporosis and long-term warfarin therapy; the trial status is completed.